Mynewsdesk LinkedIn
Investor

Financial information, reports, calendar and more

Press & News

2018-12-04

Solna, Sweden, December 4, 2018. Affibody AB (“Affibody”), a clinical stage biopharmaceutical company developing...[read more]

Financial Calendar

2018

August
Interim Report Q2 – August 23, 2018

November
Interim Report Q3 – November 16, 2018

Affibodys latest Press releases

2018-12-04

Affibody Announces Option Exercise by Biotest

Solna, Sweden, December 4, 2018. Affibody AB (“Affibody”), a clinical stage biopharmaceutical company developing a portfolio of innovative drug...[read more]

Press & News

Affibody in short

Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.

About Affibody

Upcoming reports Financial calendar

  • Interim Report Q2 (August 23, 2018)

Investor information